1. Anonymous (1998) Supplemental New Animal Drug Application for NADA 101-479 for beef cattle and non-lactating diary cattle for claim to treat inflammation in endotoxemia. Available at: http://www.fda.gov/cvm/FOI/101-479s050598.pdf accessed 10 November 2008.
2. Anonymous (2004) Supplemental New Animal Drug Application for NADA 101-479 for diary cattle for claim to treat inflammation. Available at: http://www.fda.gov/cvm/FOI/101479s081904.pdf accessed 10 November 2008.
3. Anonymous (2008) Development of target animal safety and effectiveness data to support approval of non-steroidal anti-inflammatory drugs (NSAIDs) for use in animals. http://www.fda.gov/cvm/Guidance/guide123.doc accessed 25 November 2008.
4. Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use;Blain;British Journal Clinical Pharmacology,2002
5. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2;Brooks;Rheumatology,1999